Bleeding disorders and Blood creatine phosphokinase increased

Summary:

Blood creatine phosphokinase increased is found among people with Bleeding disorders, especially for people who are female, 50-59 old.

The study analyzes which people have Blood creatine phosphokinase increased with Bleeding disorders. It is created by eHealthMe based on reports of 16 people who have Bleeding disorders from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,196 drugs and 1,648 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

What is Blood creatine phosphokinase increased?

Blood creatine phosphokinase increased is found to be associated with 1,501 drugs and 2,091 conditions by eHealthMe. Check the latest studies of Blood creatine phosphokinase increased.

On Jul, 17, 2026

16 people who have Bleeding Disorders and Blood Creatine Phosphokinase Increased are studied.

Would you have Blood creatine phosphokinase increased when you have Bleeding disorders?

Gender of people who have Bleeding Disorders and experienced Blood Creatine Phosphokinase Increased *:

female: 71.43 %
male: 28.57 %

Age of people who have Bleeding Disorders and experienced Blood Creatine Phosphokinase Increased *:

Common co-existing conditions for these people *:

High Blood Pressure: 6 people, 37.50%
Type 2 Diabetes: 6 people, 37.50%
Hypokalemia (low potassium): 5 people, 31.25%
Neuropathy Peripheral (surface nerve damage): 5 people, 31.25%
Cellulitis (infection under the skin): 5 people, 31.25%
Calcium Deficiency (lack of calcium): 5 people, 31.25%
Vitamin B Complex Deficiency: 5 people, 31.25%
Inflammation: 4 people, 25.00%
Pain: 4 people, 25.00%
Urinary Tract Infection: 3 people, 18.75%

Common drugs taken by these people *:

Cubicin: 5 people, 31.25%
Victoza: 5 people, 31.25%
Crestor: 5 people, 31.25%
Novolog: 5 people, 31.25%
Saccharomyces Boulardii: 4 people, 25.00%
Norco: 4 people, 25.00%
Calcium: 4 people, 25.00%
Hydrocodone: 4 people, 25.00%
Vitamin D3: 4 people, 25.00%
Vitamin C: 3 people, 18.75%

Common symptoms for these people *:

Acute Kidney Failure: 6 people, 37.50%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 6 people, 37.50%
Pain In Extremity: 6 people, 37.50%
Cellulitis (infection under the skin): 6 people, 37.50%
Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection): 5 people, 31.25%
Osteomyelitis (infection of bone): 5 people, 31.25%
Muscle Spasms (muscle contraction): 5 people, 31.25%
Muscle Aches (muscle pain): 5 people, 31.25%
Pain: 5 people, 31.25%
Carpal Tunnel Decompression: 5 people, 31.25%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Blood creatine phosphokinase increased?

- Check whether Blood creatine phosphokinase increased is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Bleeding disorders (24,450 reports)
Blood creatine phosphokinase increased (46,724 reports)

All the drugs that are associated with Blood creatine phosphokinase increased:

Blood creatine phosphokinase increased (1,501 drugs)

All the conditions that are associated with Blood creatine phosphokinase increased:

Blood creatine phosphokinase increased (2,091 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Blood creatine phosphokinase increased and Bleeding disorders, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.